Surgery Partners, Inc. (SGRY) Gets Required Noteholder Consents for Merger-Related Changes

Surgery Partners' subsidiary secured noteholder consents to amend its $1.225B 7.250% notes due 2032. Changes will take effect before the merger, with consenting holders receiving $5 per $1,000 of notes in 2026. The merger still requires stockholder and regulatory approvals.

Original reporting
Published Nov 20, 2026, 10:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 20, 2026, 10:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Surgery Partners, Inc. (SGRY) Gets Required Noteholder Consents for Merger-Related Changes — source image
Decision brief

The 30-second read

$SGRYBullishMed
01

Why it matters

By securing noteholder consents, Surgery Partners removes a financing and covenant-related gating item for merger-related changes, improving execution credibility while keeping the outcome conditional.

02

Market read

Traders may reassess merger-closing probability modestly, but should still wait for stockholder and regulatory approvals and satisfaction of closing conditions.

03

What to watch

Deal timing risk remains high until approvals and closing conditions are satisfied; noteholder consent does not eliminate potential last-mile deal friction.

Relevance 7/10Novelty 6/10Timing: immediately before merger, with consenting holders expected to be paid on Nov 24, 2026

Background

The company previously announced a merger agreement; this update concerns required consents to amend an indenture for its 2032 notes.

Company-level read

Ticker impact

$SGRYBullishMedium confidence
Context

Surgery Partners says its subsidiary obtained required noteholder consents to amend $1.225B of 7.250% notes, enabling merger-related changes before closing.

Expected impact

Likely modest support for the stock as the market prices improved probability of merger closing, with upside capped until approvals and closing conditions are satisfied.

Evidence & confidence

The article is a specific execution step tied to merger-related indenture amendments, but it explicitly states amendments become operative immediately before the merger if consummated, not that the merger has closed.

Market effects

Limited read-through to the healthcare services sector; this is primarily company-specific capital-structure execution for a merger.

No clear regional spillover indicated by the article.

Minimal global relevance; the news is a US-listed issuer’s debt-consent step tied to a domestic merger.

Counterpoint

Because the amendments are only operative immediately before the merger if consummated, the market may treat this as incremental and keep focus on regulatory and stockholder approvals.

Key entities

  • Surgery Partners, Inc.

    Subject of the article; obtained required noteholder consents for merger-related indenture amendments.

  • 7.250% notes due 2032

    $1,225.0M notes whose indenture amendments require noteholder consents.

Related articles

$SGRYMed

Surgery Partners, Inc. Announces Commencement of Consent Solicitation Relating to Surgery Center Holdings, Inc.’s 7.250% Senior Notes due 2032

Surgery Partners, Inc. (SGRY) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 Surgery Partners, Inc. Announces Commencement of Consent Solicitation Relating to Surgery Center Holdings, Inc.’s 7.250% Senior Notes due 2032 BRENTWOOD, Tenn., November 16, 2026 – Surgery Partners, Inc. (“Surgery Partners”) (Nasdaq: SGRY) announced today that its in

$SGRYMed

Surgery Partners: Q3 Earnings Snapshot

Surgery Partners Inc. (SGRY) reported a Q3 loss of $21.1 million, or 16 cents per share, with adjusted earnings of 16 cents per share. The company's revenue was $815.3 million. The Tennessee-based surgical facilities operator provided these financial results on Monday.